The role of her2-targeted therapies in women with her2-overexpressing metastatic breast cancer

The role of targeted therapies in the treatment of women with breast cancer has been rapidly evolving. Trastuzumab, a monoclonal antibody against the human epidermal growth factor receptor 2 (her2), was the first her2-targeted therapy that clearly demonstrated a significant clinical benefit for wome...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Dent, S., Verma, Sh., Latreille, J., Rayson, D., Clemons, M., Mackey, J., Verma, Su., Lemieux, J., Provencher, L., Chia, S., Wang, B., Pritchard, K.
Format: Artigo
Idioma:Inglês
Publicat: Multimed Inc. 2009
Matèries:
Practice Guideline Series
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2722050/
https://ncbi.nlm.nih.gov/pubmed/19672422
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars